Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Alafuzoff

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Journal of Neurochemistry|April 1, 1992
Adenylyl cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's diseaseR F Cowburn, C O'Neill, R Ravid, et al.
Brain Research|November 1, 1991
Coupling of human brain cerebral cortical alpha 2-adrenoceptors to GTP-binding proteins in Alzheimer's diseaseC O'Neill, C J Fowler, B Wiehager, et al.
Neuroscience Letters|November 25, 1991
Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's diseaseC O'Neill, R F Cowburn, B Wiehager, et al.
Neuroreport|February 24, 2001
Auditory event-related potentials differentiate patients with normal pressure hydrocephalus and patients with concomitant Alzheimer's disease verified by brain biopsyS Savolainen, J Karhu, A Pääkkönen, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
A comparison of multiplex and simplex families with Alzheimer's disease/senile dementia of Alzheimer type within a well defined populationI Alafuzoff, E Almqvist, R Adolfsson, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's diseaseI Alafuzoff, S Helisalmi, E H Heinonen, et al.
Brain Research|November 3, 1987
5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disordersJ O Marcusson, I Alafuzoff, I T Bäckström, et al.
Neuroreport|November 17, 2001
Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulationK S Laitinen, T van Groen, H Tanila, et al.
Neuroscience Letters|February 25, 2000
Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's diseaseT Tapiola, T Pirttilä, M Mikkonen, et al.
Clinical Neuropathology|June 11, 1999
Rapidly progressive multifocal leukoencephalopathy with substantial cell-mediated inflammatory response and with cognitive decline of non-Alzheimer type in a 75-year-old female patientI Alafuzoff, P Hartikainen, T Hanninen, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Journal of Neurochemistry|April 1, 1992
Adenylyl cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's diseaseR F Cowburn, C O'Neill, R Ravid, et al.
Brain Research|November 1, 1991
Coupling of human brain cerebral cortical alpha 2-adrenoceptors to GTP-binding proteins in Alzheimer's diseaseC O'Neill, C J Fowler, B Wiehager, et al.
Neuroscience Letters|November 25, 1991
Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's diseaseC O'Neill, R F Cowburn, B Wiehager, et al.
Neuroreport|February 24, 2001
Auditory event-related potentials differentiate patients with normal pressure hydrocephalus and patients with concomitant Alzheimer's disease verified by brain biopsyS Savolainen, J Karhu, A Pääkkönen, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
A comparison of multiplex and simplex families with Alzheimer's disease/senile dementia of Alzheimer type within a well defined populationI Alafuzoff, E Almqvist, R Adolfsson, et al.
European Journal of Clinical Pharmacology|May 11, 2000
Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's diseaseI Alafuzoff, S Helisalmi, E H Heinonen, et al.
Brain Research|November 3, 1987
5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disordersJ O Marcusson, I Alafuzoff, I T Bäckström, et al.
Neuroreport|November 17, 2001
Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulationK S Laitinen, T van Groen, H Tanila, et al.
Neuroscience Letters|February 25, 2000
Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's diseaseT Tapiola, T Pirttilä, M Mikkonen, et al.
Clinical Neuropathology|June 11, 1999
Rapidly progressive multifocal leukoencephalopathy with substantial cell-mediated inflammatory response and with cognitive decline of non-Alzheimer type in a 75-year-old female patientI Alafuzoff, P Hartikainen, T Hanninen, et al.
Pageof 10